|
Q4 2021
Filed on Feb 11, 2022
|
19,827
|
$10.68 - $12.26
$212K - $243K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
55,928
|
$25.76 - $30.28
$1.44M - $1.69M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
85,021
|
$26.25 - $37.05
$2.23M - $3.15M
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,534
|
$3.5 - $5.68
$43.9K - $71.2K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,588
|
$90.23 - $105.76
$775K - $908K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
18,371
|
$29.82 - $36.05
$548K - $662K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
2,235
|
$72.5 - $100.68
$162K - $225K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
19,571
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
55,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,865,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
3,730,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
8,707
|
$55.87 - $71.04
$486K - $619K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
4,355
|
$91.79 - $109.97
$400K - $479K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
9,733
|
$71.8 - $82.75
$699K - $805K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,634
|
$24.15 - $52.79
$257K - $561K
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
4,928
|
$44.42 - $77.34
$219K - $381K
|
|
Adamas Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 11, 2022
|
667,546
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
27,768
|
N/A
|
|
Ssop LLC Membership Interest A
|
Q4 2021
Filed on Feb 11, 2022
|
1,500,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
12,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 11, 2022
|
10,000
|
$0.03 - $0.06
$300 - $600
|
|
Grupo Financiero Banorte Sab D
|
Q4 2021
Filed on Feb 11, 2022
|
13,985
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
5,280
|
$19.72 - $26.38
$104K - $139K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,270
|
$44.2 - $66.86
$145K - $219K
|
|
Phillips 66 Partners LP Common
|
Q3 2021
Filed on Nov 12, 2021
|
5,453
|
N/A
|
|
Alexion Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
1,189
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
29,002
|
$15.28 - $18.46
$443K - $535K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
95,778
|
$59.92 - $59.96
$5.74M - $5.74M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
34,557
|
$26.0 - $27.01
$898K - $933K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,310
|
$167.19 - $195.67
$219K - $256K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,837
|
$65.08 - $84.84
$185K - $241K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,153
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,683
|
$43.46 - $53.08
$117K - $142K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,400
|
$46.2 - $49.31
$111K - $118K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,500
|
$43.46 - $53.08
$65.2K - $79.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,000
|
$19.72 - $26.38
$59.2K - $79.1K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,334
|
$83.64 - $90.11
$195K - $210K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
360
|
$46.2 - $49.31
$16.6K - $17.8K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
19,135
|
$16.3 - $17.26
$312K - $330K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,781
|
$126.4 - $146.6
$225K - $261K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,555
|
$32.83 - $43.0
$215K - $282K
|
|
Collateral Loan Security Ban
|
Q3 2021
Filed on Nov 12, 2021
|
79,770
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
19,236
|
$0.14 - $0.25
$2.69K - $4.81K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
54,349
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
31,075
|
N/A
|
|
Blackstone Real Estate Income
|
Q3 2021
Filed on Nov 12, 2021
|
574,832
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
15,175
|
$24.02 - $40.73
$365K - $618K
|
|